Crescita Therapeutics (TSE:CTX) Announces Quarterly Earnings Results

Crescita Therapeutics (TSE:CTX) posted its quarterly earnings data on Tuesday. The company reported C($0.04) earnings per share for the quarter, FiscalAI reports. The company had revenue of C$5.96 million during the quarter. Crescita Therapeutics had a return on equity of 2.92% and a net margin of 2.07%.

Crescita Therapeutics Trading Down 1.3%

Crescita Therapeutics stock opened at C$0.74 on Tuesday. Crescita Therapeutics has a 12-month low of C$0.40 and a 12-month high of C$0.75. The company has a debt-to-equity ratio of 2.98, a current ratio of 3.12 and a quick ratio of 2.29. The stock has a market capitalization of C$13.77 million, a PE ratio of 37.00 and a beta of -0.39. The firm has a 50 day simple moving average of C$0.54 and a 200-day simple moving average of C$0.49.

About Crescita Therapeutics

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.